Akebia Therapeutics, Inc.

AKBANasdaq· Pharmaceutical Preparations

Price History

Revenue

$236.2M

▲ 47.5% YoY

Net Income

-$5.3M

▲ 92.3% YoY

EPS

$-0.02

▲ 93.9% YoY

Cash

$184.8M

▲ 256.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.